BTI
ADPT icon

Blue Trust Inc’s Adaptive Biotechnologies ADPT Stock Holding History

Blue Trust Inc’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21
Closed -$245 – 2566
2025
Q2 		$245 Buy
+21
New +$191 ﹤0.01% 2370
2024
Q4 		– Sell
-91
Closed -$329 – 2431
2024
Q3 		$329 Buy
+91
New +$396 ﹤0.01% 2829
2024
Q1 		– Sell
-364
Closed -$2K – 2161
2023
Q4 		$2K Buy
+364
New +$1.66K ﹤0.01% 2084
2023
Q1 		– Sell
-55
Closed – – 2271
2022
Q4 		$0 Hold
55
– – ﹤0.01% 2195
2022
Q3 		$0 Buy
+55
New +$518 ﹤0.01% 2059

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blue Trust Inc's ADPT Position: Q3 2025 in Review

Blue Trust Inc sold out of Adaptive Biotechnologies (ADPT) in Q3 2025, closing a stake of 21 shares — an estimated $245 sold.

Blue Trust Inc first reported a position in ADPT in Q3 2022 and held it in 5 quarters. The position peaked at $2K in Q4 2023. 271 funds tracked by Wall St. Rank hold ADPT as of Q3 2025.

  • Blue Trust Inc reported no remaining Adaptive Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Blue Trust Inc sold 21 Adaptive Biotechnologies shares in Q3 2025, an estimated $245.
  • Blue Trust Inc first reported a position in Adaptive Biotechnologies in Q3 2022 and held it in 5 quarters.
  • Blue Trust Inc's Adaptive Biotechnologies position peaked at $2K in Q4 2023.
  • 271 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2025.

Based on Blue Trust Inc's 13F filing for Q3 2025, filed 16 Oct 2025.